Teprotumumab vs Intravenous Methylprednisolone for Thyroid Eye Disease: Is There Still a Role for Steroids?

Ashley A. Campbell

doi:10.1001/jamaophthalmol.2021.6376

Teprotumumab vs Intravenous Methylprednisolone for Thyroid Eye Disease: Is There Still a Role for Steroids?

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	335-336
Number of pages	2
Journal	JAMA ophthalmology
Volume	140
Issue number	4
DOIs	https://doi.org/10.1001/jamaophthalmol.2021.6376
State	Published - Apr 2022

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1001/jamaophthalmol.2021.6376

Cite this

@article{6f17154f03fa4c6a8aaec1d192fdcd11,

title = "Teprotumumab vs Intravenous Methylprednisolone for Thyroid Eye Disease: Is There Still a Role for Steroids?",

author = "Campbell, {Ashley A.}",

year = "2022",

month = apr,

doi = "10.1001/jamaophthalmol.2021.6376",

language = "English (US)",

volume = "140",

pages = "335--336",

journal = "JAMA Ophthalmology",

issn = "2168-6165",

publisher = "American Medical Association",

number = "4",

}

TY - JOUR

T1 - Teprotumumab vs Intravenous Methylprednisolone for Thyroid Eye Disease

T2 - Is There Still a Role for Steroids?

AU - Campbell, Ashley A.

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85124976184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124976184&partnerID=8YFLogxK

U2 - 10.1001/jamaophthalmol.2021.6376

DO - 10.1001/jamaophthalmol.2021.6376

M3 - Comment/debate

C2 - 35175298

AN - SCOPUS:85124976184

SN - 2168-6165

VL - 140

SP - 335

EP - 336

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

IS - 4

ER -

Teprotumumab vs Intravenous Methylprednisolone for Thyroid Eye Disease: Is There Still a Role for Steroids?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this